Key Metrics
CiteScore 

12.1
Impact Factor 

5 - 10
SJR 

Q1Dermatology

SNIP 

3.02
Recommended pre-submission checks
Powered by 

Topics Covered on American Journal of Clinical Dermatology
American Journal of Clinical Dermatology Journal Specifications
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in American Journal of Clinical Dermatology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in American Journal of Clinical Dermatology
Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials.
- 7 Aug 2026
- American journal of clinical dermatology
Systemic Comorbidities of Keloid and Hypertrophic Scars: A Phenome-Wide Association Study in a Multiethnic U.S. Pediatric Cohort.
- 2 Aug 2026
- American journal of clinical dermatology
Correction to: Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies.
- 28 Jul 2026
- American journal of clinical dermatology
Efficacy and Safety of Oral Janus Kinase Inhibitors in Adults and Adolescents with Alopecia Areata: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
- 28 Jul 2026
- American journal of clinical dermatology
Updated Integrated Safety Analysis of Ritlecitinib up to ~5Years in Patients with Alopecia Areata from the ALLEGRO Clinical Trial Program.
- 22 Jul 2026
- American journal of clinical dermatology
A Systematic Review of Factors Influencing Adult Adherence to Topical Medications in Atopic Dermatitis.
- 9 Jul 2026
- American journal of clinical dermatology
Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials.
- 7 Aug 2026
- American journal of clinical dermatology
Systemic Comorbidities of Keloid and Hypertrophic Scars: A Phenome-Wide Association Study in a Multiethnic U.S. Pediatric Cohort.
- 2 Aug 2026
- American journal of clinical dermatology
Correction to: Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies.
- 28 Jul 2026
- American journal of clinical dermatology
Efficacy and Safety of Oral Janus Kinase Inhibitors in Adults and Adolescents with Alopecia Areata: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
- 28 Jul 2026
- American journal of clinical dermatology
Updated Integrated Safety Analysis of Ritlecitinib up to ~5Years in Patients with Alopecia Areata from the ALLEGRO Clinical Trial Program.
- 22 Jul 2026
- American journal of clinical dermatology
A Systematic Review of Factors Influencing Adult Adherence to Topical Medications in Atopic Dermatitis.
- 9 Jul 2026
- American journal of clinical dermatology